Financings in Brief: Biex
This article was originally published in The Gray Sheet
Executive Summary
Biex: Completes $10.3 mil. private placement of 4.1 mil. shares of preferred stock at $2.50 per share. The Dublin, California firm has tabbed the proceeds for expanded R&D and for ramp-up of sales and marketing capabilities for its SalEst test. A premarket approval application for the test, designed to predict the risk of preterm delivery, was recently granted expedited review by FDA ("The Gray Sheet" Sept. 1, In Brief). The financing was arranged by Robertson Stephens & Company...